107 related articles for article (PubMed ID: 21703461)
21. Where are we going with regional therapy for melanoma?
Tyler D
Ann Surg Oncol; 2004 May; 11(5):455-7. PubMed ID: 15078631
[No Abstract] [Full Text] [Related]
22. [Working group of Dermatologic Oncology ADO. Second-line therapy in stage IV melanoma].
J Dtsch Dermatol Ges; 2007 Oct; 5(10):959. PubMed ID: 17910683
[No Abstract] [Full Text] [Related]
23. High-dose interferon versus GM2 vaccine in high-risk malignant melanoma.
Wilson K
J Clin Oncol; 2001 Dec; 19(23):4350. PubMed ID: 11731522
[No Abstract] [Full Text] [Related]
24. Reactive oxygen species may have antitumor activity in metastatic melanoma.
Tuma RS
J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
[No Abstract] [Full Text] [Related]
25. [Guidelines for proper use of antineoplastic agents. Skin cancer].
Uhara H; Saida T
Gan To Kagaku Ryoho; 2002 Jun; 29(6):1074-80. PubMed ID: 12109448
[No Abstract] [Full Text] [Related]
26. Adjuvant therapy of melanoma.
Geskin L; Brown CR; Kirkwood JM
Semin Cutan Med Surg; 2003 Mar; 22(1):55-67. PubMed ID: 12773014
[No Abstract] [Full Text] [Related]
27. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
28. Mucosal melanoma.
Seigler HF
J Surg Oncol; 2004 Jul; 86(4):187-8. PubMed ID: 15221925
[No Abstract] [Full Text] [Related]
29. Predictors of response to interferon therapy.
Gogas H; Kirkwood JM
Curr Opin Oncol; 2009 Mar; 21(2):138-43. PubMed ID: 19532015
[TBL] [Abstract][Full Text] [Related]
30. Novel treatment strategies for malignant melanoma: a new beginning?
Kasper B; D'Hondt V; Vereecken P; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
[TBL] [Abstract][Full Text] [Related]
31. Treatment for metastatic malignant melanoma: old drugs and new strategies.
Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
[TBL] [Abstract][Full Text] [Related]
32. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
[No Abstract] [Full Text] [Related]
33. Treatments for metastatic melanoma: synthesis of evidence from randomized trials.
Lui P; Cashin R; Machado M; Hemels M; Corey-Lisle PK; Einarson TR
Cancer Treat Rev; 2007 Dec; 33(8):665-80. PubMed ID: 17919823
[TBL] [Abstract][Full Text] [Related]
34. Treating patients with melanoma with interferon.
Cook J; Zitelli JA
Arch Dermatol; 1997 Mar; 133(3):387-9. PubMed ID: 9080905
[No Abstract] [Full Text] [Related]
35. [In vitro drug sensitivity profiling in melanoma].
Ugurel S
J Dtsch Dermatol Ges; 2008 Jul; 6(7):611. PubMed ID: 18611186
[No Abstract] [Full Text] [Related]
36. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
Moschos SJ; Kirkwood JM; Konstantinopoulos PA
J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
[No Abstract] [Full Text] [Related]
37. Randomized trials in melanoma: an update.
Eggermont AM
Surg Oncol Clin N Am; 2006 Apr; 15(2):439-51. PubMed ID: 16632225
[TBL] [Abstract][Full Text] [Related]
38. Role of interferon in melanoma: old hopes and new perspectives.
Sanlorenzo M; Vujic I; Carnevale-Schianca F; Quaglino P; Gammaitoni L; Fierro MT; Aglietta M; Sangiolo D
Expert Opin Biol Ther; 2017 Apr; 17(4):475-483. PubMed ID: 28274138
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of primary and regional melanoma].
Dreno B
Rev Prat; 2004 Jun; 54(11):1203-9. PubMed ID: 15496027
[TBL] [Abstract][Full Text] [Related]
40. [Interferons in the therapy of solid tumors].
Tomao S; Mozzicafreddo A; Raffaele M; Romiti A; Papò MA; Campisi C
Clin Ter; 1995; 146(8-9):491-502. PubMed ID: 8536432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
